These results uncover a novel role and underlying mechanism of FOXS1 in the progression of CRC, suggesting that the FOXS1/CXCL8 axis may be a promising anti-angiogenesis and tumor invasion target for the treatment of metastatic CRC. Here, CXCL8 is linked to colorectal carcinoma.